Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
8,484,410
-
Shares change
-
+2,468,133
-
Total reported value, excl. options
-
$30,665,000
-
Value change
-
+$8,984,489
-
Number of buys
-
3
-
Number of sells
-
2
-
Price
-
$3.61
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2014
As of 31 Dec 2014 Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,484,410 shares of stock of the company.
Largest 9 holders included NEA Management Company, LLC, GREAT POINT PARTNERS LLC, RA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, DEUTSCHE BANK AG\, Cheyne Capital Management (UK) LLP, BANK OF MONTREAL /CAN/, ROYAL BANK OF CANADA, and Tower Research Capital LLC (TRC).
This table shows 9 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.